As of 2024-12-14, the EV/EBITDA ratio of Affimed NV (AFMD) is -0.63. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AFMD's latest enterprise value is 39.00 mil USD. AFMD's TTM EBITDA according to its financial statements is -61.80 mil USD. Dividing these 2 quantities gives us the above AFMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.8x - 11.8x | 7.8x |
| Forward P/E multiples | 3.3x - 10.0x | 6.6x |
| Fair Price | (16.59) - (43.18) | (31.36) |
| Upside | -861.0% - -2080.5% | -1538.6% |
| Date | EV/EBITDA |
| 2024-12-12 | -0.60 |
| 2024-12-11 | -0.62 |
| 2024-12-10 | -0.63 |
| 2024-12-09 | -0.65 |
| 2024-12-06 | -0.63 |
| 2024-12-05 | -0.63 |
| 2024-12-04 | -0.67 |
| 2024-12-03 | -0.67 |
| 2024-12-02 | -0.74 |
| 2024-11-29 | -0.75 |
| 2024-11-27 | -0.75 |
| 2024-11-26 | -0.76 |
| 2024-11-25 | -0.79 |
| 2024-11-22 | -0.70 |
| 2024-11-21 | -0.70 |
| 2024-11-20 | -0.72 |
| 2024-11-19 | -0.79 |
| 2024-11-18 | -0.83 |
| 2024-11-15 | -0.90 |
| 2024-11-14 | -0.94 |
| 2024-11-13 | -0.96 |
| 2024-11-12 | -0.97 |
| 2024-11-11 | -0.98 |
| 2024-11-08 | -0.99 |
| 2024-11-07 | -0.98 |
| 2024-11-06 | -0.92 |
| 2024-11-05 | -0.94 |
| 2024-11-04 | -0.85 |
| 2024-11-01 | -0.85 |
| 2024-10-31 | -0.84 |
| 2024-10-30 | -0.87 |
| 2024-10-29 | -0.87 |
| 2024-10-28 | -0.87 |
| 2024-10-25 | -0.86 |
| 2024-10-24 | -0.86 |
| 2024-10-23 | -0.88 |
| 2024-10-22 | -0.90 |
| 2024-10-21 | -0.88 |
| 2024-10-18 | -0.92 |
| 2024-10-17 | -0.86 |
| 2024-10-16 | -0.87 |
| 2024-10-15 | -0.82 |
| 2024-10-14 | -0.82 |
| 2024-10-11 | -0.79 |
| 2024-10-10 | -0.79 |
| 2024-10-09 | -0.81 |
| 2024-10-08 | -0.82 |
| 2024-10-07 | -0.83 |
| 2024-10-04 | -0.84 |
| 2024-10-03 | -0.85 |